The sale of the bankrupt DNA data bank 23andMe is facing delays as the company tries to find a lead bidder that can quickly clear regulatory hurdles and guarantee customer privacy rules will be honored. The former Silicon Valley startup …
The U.S. Federal Trade Commission is concerned about the potential sale or transfer of Americans’ personal information by 23andMe ancestry testing company which recently filed for bankruptcy, the agency’s chairman said on Monday. Any purchaser of 23andMe assets should agree …
Millions of Americans who sent their saliva to 23andMe in the hopes of finding lost relatives or identifying health risks buried in their DNA now face seeing their genetic information sold to the highest bidder as part of the company’s …
23andMe will pay $30 million and provide three years of security monitoring to settle a lawsuit accusing the genetics testing company of failing to protect the privacy of 6.9 million customers whose personal information was exposed in a data breach …
Some 6.9 million 23andMe customers had their data compromised after an anonymous hacker accessed user profiles and posted them for sale on the internet earlier this year, the company said on Monday. The compromised data included users’ ancestry information as …
In a move that has come to be expected following most cyberattacks, two victims of the recent 23andMe data breach have filed a class action lawsuit. The suit, filed in U.S. District Court for the Northern District of California alleges …
An anonymous hacker is claiming to be selling “millions” of genetic profiles cobbled together from hijacked 23andMe customer accounts. The seller suggested the profiles, which include email addresses, photos, gender, date of birth and DNA ancestry, could be used to …
The genetic test firm 23andMe Inc.’s clash with U.S. regulators over the direct sale of its gene analysis service to consumers signals stiffer oversight of thousands of tests in an industry predicted to increase fivefold in size. The Personal Genome …
The U.S. Food and Drug Administration has warned 23andMe, a company backed by Google Inc., to halt sales of its genetic tests because they have not received regulatory clearance. 23andMe, which was founded in 2006 by Anne Wojcicki, sells a …
